Contact this trialFirst, we need to learn more about you.
Radioactive Drug
Radionuclide Therapies for Neuroendocrine Tumors
Recruiting1 awardPhase < 1
Iowa City, Iowa
This trial is testing different doses of two radioactive drugs (131I-MIBG and 90Y-DOTATOC) to see which is best tolerated when given together to treat neuroendocrine tumors in the midgut.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service